Clinical, Pathologic, and Dosimetric Predictors of Head and Neck Lymphedema Following Definitive or Adjuvant Radiation Therapy for Head and Neck Cancer. Journal Abstract

Clinical, Pathologic, and Dosimetric Predictors of Head and Neck Lymphedema Following Definitive or Adjuvant Radiation Therapy for Head and Neck Cancer.

Publication Date: 2024 Sep

Full Text Sources

Authors

Kevin R Rogacki; P Troy Teo; Mahesh Gopalakrishnan; Suvidya Lakshmi Pachigolla; Clayton E Lyons; Mohamed E Abazeed; Indra Das; Bharat B Mittal; Michelle Gentile

Abstract

OBJECTIVE

Head and neck lymphedema (HNL) following radiation therapy for head and neck cancer (HNC) causes patient morbidity. Predicting individual patients' risk of HNL after treatment is challenging. We aimed to identify the demographic, disease-related, and treatment-related factors associated with external and internal HNL following treatment of HNC with definitive or adjuvant radiation therapy.

Source

Advances in radiation oncology

Pub Types(s)

Journal Article

Language

English

PubMed ID

39184143